Should P2Y12 Antagonists Be Continued Through CABG in Patients with ACS?

Presenter: Adnan Kastrati

REGISTER for free or LOG IN to view this content

Should P2Y12 Antagonists Be Continued Through CABG in Patients with ACS?

We Recommend